TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 8580801

Group type: EXPERIMENTAL
Intervention: ProMECE‐CytaBOM (P‐C)
Number of subjects: 210

Group type: COMPARATOR
Intervention: MACOP‐B (M‐B)
Number of subjects: 210
Study: 2561036

Group type: EXPERIMENTAL
Intervention: metoprolol (200 mg/die)
Number of subjects: 121

Group type: COMPARATOR
Intervention: gallopamil
Number of subjects: 121

Group type: EXPERIMENTAL
Intervention: combined therapy with atenolol (50 mg) and nifedipine (20 mg)
Number of subjects: 121

Group type: EXPERIMENTAL
Intervention: 200 mg acebutolol and 20 mg nifedipine
Number of subjects: 121

Group type: EXPERIMENTAL
Intervention: 50 mg atenolol and 10 mg enalapril
Number of subjects: 121

Group type: EXPERIMENTAL
Intervention: all treatments
Number of subjects: 121
Study: 807222

Group type: EXPERIMENTAL
Intervention: naproxen
Number of subjects: 64
Study: 28103950

Group type: EXPERIMENTAL
Intervention: Bilateral ventilation tube insertion
Number of subjects: 230

Group type: COMPARATOR
Intervention: Treatment as usual (no tube)
Number of subjects: 230
Study: 25820119

Group type: EXPERIMENTAL
Intervention: Computer Aided Surgery (CAS) performed by trainee surgeons
Number of subjects: 92

Group type: COMPARATOR
Intervention: Computer Aided Surgery (CAS) performed by consultant orthopedic surgeons
Number of subjects: 92
Study: 23722573

Group type: EXPERIMENTAL
Intervention: Squat posture with mental processing using arithmetic tasks
Number of subjects: 13

Group type: EXPERIMENTAL
Intervention: Stoop posture with mental processing using arithmetic tasks
Number of subjects: 13

Group type: COMPARATOR
Intervention: Squat posture without mental processing
Number of subjects: 13

Group type: COMPARATOR
Intervention: Stoop posture without mental processing
Number of subjects: 13
Study: 21855244

Group type: EXPERIMENTAL
Intervention: Boswellia serrata gum resin extracts (BSE) at a high dose of 4200 mg per day
Number of subjects: 27

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 27
Study: 19570388

Group type: EXPERIMENTAL
Intervention: Carotid endarterectomy (CEA)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Carotid stenting (CAS)
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Cost of hospitalization for CEA
Number of subjects: 40

Group type: COMPARATOR
Intervention: Cost of hospitalization for CAS
Number of subjects: 40
Study: 17274236

Group type: EXPERIMENTAL
Intervention: Herbal mouthwash containing the pericarp extract of Garcinia mangostana L
Number of subjects: 60

Group type: COMPARATOR
Intervention: Placebo mouthwash
Number of subjects: 60
Study: 15569120

Group type: EXPERIMENTAL
Intervention: Omeprazole
Number of subjects: 829

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 829
Study: 11571769

Group type: EXPERIMENTAL
Intervention: Higher behavioral disturbance group (n = 148)
Number of subjects: 383

Group type: COMPARATOR
Intervention: Lower behavioral disturbance group (n = 235)
Number of subjects: 383
Study: 9778079

Group type: EXPERIMENTAL
Intervention: Diabetes Mellitus (DM) alone
Number of subjects: 2531

Group type: EXPERIMENTAL
Intervention: Hypertension (HTN) alone
Number of subjects: 2531

Group type: EXPERIMENTAL
Intervention: Both DM and HTN
Number of subjects: 2531

Group type: EXPERIMENTAL
Intervention: Smoking with DM and HTN
Number of subjects: 2531
Study: 7866636

Group type: EXPERIMENTAL
Intervention: Triplex PCR
Number of subjects: 47

Group type: COMPARATOR
Intervention: Culture methods
Number of subjects: 47

Group type: COMPARATOR
Intervention: Microscopy
Number of subjects: 47
Study: 3154688

Group type: EXPERIMENTAL
Intervention: molsidomine
Number of subjects: 270

Group type: COMPARATOR
Intervention: placebo
Number of subjects: 270
Study: 31330515

Group type: EXPERIMENTAL
Intervention: Cognitive frailty
Number of subjects: 495
Study: 31439409

Group type: EXPERIMENTAL
Intervention: Effective connectivity from left anterior cingulate cortex (ACC) to right hippocampus
Number of subjects: 27

Group type: EXPERIMENTAL
Intervention: Opioid-word Stroop task
Number of subjects: 27
Study: 28900247

Group type: EXPERIMENTAL
Intervention: pRJ 1.2 g/d
Number of subjects: 194

Group type: EXPERIMENTAL
Intervention: pRJ 4.8 g/d
Number of subjects: 194

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 194

Group type: EXPERIMENTAL
Intervention: Physical performance tests (six-minute walk test, timed up and go test, standing on one leg with eyes closed)
Number of subjects: 194
Study: 26482492

Group type: EXPERIMENTAL
Intervention: Unilateral interleaved deep brain stimulation in the subthalamic nucleus/substantia nigra pars reticulata region
Number of subjects: 0
Study: 23359265

Group type: EXPERIMENTAL
Intervention: Nevirapine 200 mg once-daily regimen
Number of subjects: 532
Study: 20683766

Group type: EXPERIMENTAL
Intervention: omega-3 fatty acids (1.3 g/day)
Number of subjects: 27

Group type: COMPARATOR
Intervention: placebo
Number of subjects: 27
Study: 19666638

Group type: EXPERIMENTAL
Intervention: Right ventricular pacing (VPinSR)
Number of subjects: 554

Group type: COMPARATOR
Intervention: Synchronous pacing modalities (ASVP, APVP, APVS)
Number of subjects: 554
Study: 16960025

Group type: EXPERIMENTAL
Intervention: Caloric restriction (CR) - 20% calorically-restricted diet (n = 19)
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: Exercise (EX) - designed to produce a similar energy deficit (n = 19)
Number of subjects: 48

Group type: COMPARATOR
Intervention: Healthy lifestyle control (HL) - control group (n = 10)
Number of subjects: 48
Study: 15376310

Group type: EXPERIMENTAL
Intervention: Tacrolimus
Number of subjects: 79

Group type: COMPARATOR
Intervention: Cyclosporine
Number of subjects: 79
Study: 11694665

Group type: EXPERIMENTAL
Intervention: DTaP SB
Number of subjects: 4217

Group type: EXPERIMENTAL
Intervention: DTaP CB
Number of subjects: 4217

Group type: COMPARATOR
Intervention: DT
Number of subjects: 4217
Study: 9493479

Group type: EXPERIMENTAL
Intervention: Ginkgo biloba/ginseng combination 320 mg b.i.d.
Number of subjects: 64

Group type: EXPERIMENTAL
Intervention: Ginkgo biloba/ginseng combination 80 mg b.i.d.
Number of subjects: 64

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 64
Study: 7971111

Group type: EXPERIMENTAL
Intervention: Conditions designed to promote integration of shape and texture
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Conditions designed to impede integration of shape and texture
Number of subjects: 0
Study: 2822294

Group type: EXPERIMENTAL
Intervention: Naloxone (10 mg as a bolus)
Number of subjects: 10

Group type: COMPARATOR
Intervention: Naloxone after dexamethasone (2 mg)
Number of subjects: 10
Study: 31451566

Group type: EXPERIMENTAL
Intervention: Cognitive training (CT) intervention for 16 weeks
Number of subjects: 0

Group type: COMPARATOR
Intervention: Attention control
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Cognitive training (CT) intervention
Number of subjects: 0
Study: 28858418

Group type: EXPERIMENTAL
Intervention: Contracted endodontic cavity (CEC) access with 35% carbamide peroxide
Number of subjects: 42

Group type: COMPARATOR
Intervention: Traditional endodontic cavity (TEC) access with 35% carbamide peroxide
Number of subjects: 42

Group type: COMPARATOR
Intervention: Comparison of CEC and TEC designs
Number of subjects: 42
Study: 27849643

Group type: EXPERIMENTAL
Intervention: Diclofenac (100 mg)
Number of subjects: 372

Group type: EXPERIMENTAL
Intervention: Indomethacin (100 mg)
Number of subjects: 372

Group type: COMPARATOR
Intervention: Naproxen (500 mg)
Number of subjects: 372

Group type: EXPERIMENTAL
Intervention: Diclofenac and Indomethacin
Number of subjects: 372

Group type: COMPARATOR
Intervention: Naproxen
Number of subjects: 372
Study: 26615516

Group type: EXPERIMENTAL
Intervention: Esmolol (500 mcg/kg bolus 10 min before induction, followed by 200 mcg/kg/min infusion)
Number of subjects: 42

Group type: COMPARATOR
Intervention: Control group (no esmolol)
Number of subjects: 42
Study: 22954393

Group type: EXPERIMENTAL
Intervention: Standard-dose tirofiban (10 μg/kg bolus, 0.15 μg/kg/min infusion for 48 h)
Number of subjects: 163

Group type: COMPARATOR
Intervention: Half-dose tirofiban (5 μg/kg bolus, 0.075 μg/kg/min infusion for 48 h)
Number of subjects: 163

Group type: COMPARATOR
Intervention: Half-dose tirofiban
Number of subjects: 163

Group type: EXPERIMENTAL
Intervention: Both groups (Standard-dose and Half-dose tirofiban)
Number of subjects: 163
Study: 20803038

Group type: EXPERIMENTAL
Intervention: Internal jugular access
Number of subjects: 403

Group type: EXPERIMENTAL
Intervention: Subclavian access
Number of subjects: 403

Group type: EXPERIMENTAL
Intervention: Cephalic vein access
Number of subjects: 403

Group type: EXPERIMENTAL
Intervention: Palliative therapies
Number of subjects: 403

Group type: COMPARATOR
Intervention: Depression and anxiety scores (HADS)
Number of subjects: 403
Study: 17845540

Group type: EXPERIMENTAL
Intervention: IFN 3 MU daily plus ribavirin (RBV) 1000 mg/day for 4 weeks, followed by IFN 3 MU TIW plus RBV 1000 mg/day for 44 weeks (induction)
Number of subjects: 876

Group type: EXPERIMENTAL
Intervention: IFN 5 MU B.I.D. plus RBV 1000-1200 mg/day for 2 weeks, followed by pegylated IFN (PEG-IFN) 75-150 mug weekly plus RBV 1000-1200 mg/day for 46 weeks (induction)
Number of subjects: 876

Group type: COMPARATOR
Intervention: IFN 3 MU TIW plus RBV 1000 mg/day for 48 weeks (non-induction)
Number of subjects: 876

Group type: COMPARATOR
Intervention: PEG-IFN 75-150 mug weekly plus RBV 1000-1200 mg/day for 48 weeks (non-induction)
Number of subjects: 876
Study: 15168037

Group type: EXPERIMENTAL
Intervention: Eccentric exercise followed by a CHO-rich diet (> 10 g/kg body mass/24 h)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Resting (no exercise)
Number of subjects: 20
Study: 11594097

Group type: EXPERIMENTAL
Intervention: Laparoscopic GBP
Number of subjects: 101

Group type: EXPERIMENTAL
Intervention: Open GBP
Number of subjects: 101
Study: 9853438

Group type: EXPERIMENTAL
Intervention: Topical recombinant bovine basic fibroblast growth factor (rbFGF) 150 AU/cm2 daily
Number of subjects: 600

Group type: COMPARATOR
Intervention: Placebo plus vehicle
Number of subjects: 600
Study: 7985636

Group type: EXPERIMENTAL
Intervention: Vitamin B-12 alone
Number of subjects: 184

Group type: EXPERIMENTAL
Intervention: Vitamin B-12 combined with folate
Number of subjects: 184

Group type: COMPARATOR
Intervention: Folate alone
Number of subjects: 184

Group type: COMPARATOR
Intervention: Untreated group
Number of subjects: 184
Study: 2577555

Group type: EXPERIMENTAL
Intervention: Adjuvant portal therapy of the liver with resection of the colorectal primary malignancy
Number of subjects: 657

Group type: COMPARATOR
Intervention: Adjuvant treatment of the liver following curative resection of colorectal liver metastases
Number of subjects: 657

Group type: EXPERIMENTAL
Intervention: Palliative local chemotherapy (FUDR, pump) for unresectable colorectal liver metastases
Number of subjects: 657

Group type: EXPERIMENTAL
Intervention: Chemoembolisation (Frankfurt method) for primary non-resectable liver malignancies
Number of subjects: 657
Study: 31597476

Group type: EXPERIMENTAL
Intervention: Low-level transcutaneous electrical stimulation (LLTS) of the greater auricular nerve, amplitude 1 mA, frequency 1 Hz for 40 minutes, followed by a 20 minutes break, for up to 2 weeks after cardiac surgery
Number of subjects: 40

Group type: COMPARATOR
Intervention: Control group (sham stimulation)
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Low-level transcutaneous electrical stimulation (LLTS) of the greater auricular nerve
Number of subjects: 40
Study: 29723874

Group type: EXPERIMENTAL
Intervention: Warfarin (anticoagulant interrupted)
Number of subjects: 7193

Group type: EXPERIMENTAL
Intervention: Higher-dose edoxaban regimen (HDER) (anticoagulant interrupted)
Number of subjects: 7193

Group type: EXPERIMENTAL
Intervention: Lower-dose edoxaban regimen (LDER) (anticoagulant interrupted)
Number of subjects: 7193

Group type: EXPERIMENTAL
Intervention: Warfarin (anticoagulant continued)
Number of subjects: 7193

Group type: EXPERIMENTAL
Intervention: Higher-dose edoxaban regimen (HDER) (anticoagulant continued)
Number of subjects: 7193

Group type: EXPERIMENTAL
Intervention: Lower-dose edoxaban regimen (LDER) (anticoagulant continued)
Number of subjects: 7193
Study: 26250501

Group type: EXPERIMENTAL
Intervention: Muffins enriched with 20% sour cherry pomace (CP)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Muffins enriched with 30% sour cherry pomace (CP)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Muffins enriched with sour cherry pomace (CP)
Number of subjects: 0
Study: 25362669

Group type: EXPERIMENTAL
Intervention: Disposable ECG‐LWs
Number of subjects: 7238

Group type: COMPARATOR
Intervention: Reusable ECG‐LWs
Number of subjects: 7238
Study: 22525595

Group type: COMPARATOR
Intervention: Retrospective ECG‐gated protocol (group 1)
Number of subjects: 96

Group type: EXPERIMENTAL
Intervention: Prospective ECG‐triggering protocol with acquisition window of 380 ms (group 2)
Number of subjects: 96

Group type: EXPERIMENTAL
Intervention: Prospective ECG‐triggering protocol with acquisition window of 200 ms (group 3)
Number of subjects: 96
Study: 19230717

Group type: EXPERIMENTAL
Intervention: Self-monitoring of blood glucose (SMBG)
Number of subjects: 1102
Study: 17850734

Group type: EXPERIMENTAL
Intervention: Insulin plus pioglitazone
Number of subjects: 32

Group type: COMPARATOR
Intervention: Insulin
Number of subjects: 32
Study: 15780111

Group type: EXPERIMENTAL
Intervention: Regular ultrasound examinations every 3 months in addition to traditional screening methods.
Number of subjects: 192

Group type: COMPARATOR
Intervention: Traditional screening methods only (without ultrasound).
Number of subjects: 192
Study: 14628158

Group type: EXPERIMENTAL
Intervention: Removal of hypertrophied anal papillae and fibrous anal polyps by radiofrequency surgery
Number of subjects: 140

Group type: COMPARATOR
Intervention: Control group (no removal of polyps and papillae)
Number of subjects: 140
Study: 10918084

Group type: EXPERIMENTAL
Intervention: Creatine (Cr) 5 g + 5 g maltodextrin
Number of subjects: 14

Group type: COMPARATOR
Intervention: Placebo (P) 5 g maltodextrin
Number of subjects: 14

Group type: EXPERIMENTAL
Intervention: Creatine (Cr)
Number of subjects: 14

Group type: COMPARATOR
Intervention: Placebo (P)
Number of subjects: 14
Study: 8893110

Group type: EXPERIMENTAL
Intervention: Cetirizine 10 mg once daily
Number of subjects: 188

Group type: EXPERIMENTAL
Intervention: Hydroxyzine 25 mg tid
Number of subjects: 188

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 188
Study: 1994554

Group type: EXPERIMENTAL
Intervention: Takeda TM 2420 automatic ambulant device for measuring blood pressure
Number of subjects: 69

Group type: COMPARATOR
Intervention: Hawksley random zero manometer
Number of subjects: 69

Group type: EXPERIMENTAL
Intervention: Takeda TM 2420 24-hour monitoring
Number of subjects: 69
Study: 6141704

Group type: EXPERIMENTAL
Intervention: Relaxation therapy (R)
Number of subjects: 103

Group type: EXPERIMENTAL
Intervention: Basal therapy (B)
Number of subjects: 103

Group type: EXPERIMENTAL
Intervention: Therapist‐directed prolonged exposure in vivo (PE)
Number of subjects: 103

Group type: EXPERIMENTAL
Intervention: Dynamically oriented supportive therapy (ST)
Number of subjects: 103
Study: 31059148

Group type: EXPERIMENTAL
Intervention: Microscope and micro-camera assessment with 3 mm membrane elevation height (MEH)
Number of subjects: 5

Group type: EXPERIMENTAL
Intervention: Microscope and micro-camera assessment with 6 mm membrane elevation height (MEH)
Number of subjects: 5

Group type: EXPERIMENTAL
Intervention: Microscope and micro-camera assessment
Number of subjects: 5
Study: 28625832

Group type: EXPERIMENTAL
Intervention: Low FODMAP diet
Number of subjects: 104

Group type: EXPERIMENTAL
Intervention: Probiotic
Number of subjects: 104

Group type: COMPARATOR
Intervention: Sham diet
Number of subjects: 104
Study: 26928962

Group type: EXPERIMENTAL
Intervention: ENGERIX-B
Number of subjects: 72

Group type: COMPARATOR
Intervention: Sci-B-Vac
Number of subjects: 72
Study: 24439238

Group type: EXPERIMENTAL
Intervention: Day patient treatment (DP) after 3 weeks of inpatient care
Number of subjects: 172

Group type: COMPARATOR
Intervention: Inpatient treatment (IP)
Number of subjects: 172

Group type: EXPERIMENTAL
Intervention: Both groups (IP and DP)
Number of subjects: 172
Study: 22823994

Group type: EXPERIMENTAL
Intervention: Standard of care treatment + SABR to all sites of known disease
Number of subjects: 99

Group type: COMPARATOR
Intervention: Current standard of care treatment
Number of subjects: 99
Study: 18562265

Group type: EXPERIMENTAL
Intervention: Wound drains
Number of subjects: 107

Group type: COMPARATOR
Intervention: No wound drains
Number of subjects: 107
Study: 17460714

Group type: EXPERIMENTAL
Intervention: Once daily ramipril 10 mg
Number of subjects: 29

Group type: EXPERIMENTAL
Intervention: Twice daily ramipril 5 mg
Number of subjects: 29
Study: 15827396

Group type: EXPERIMENTAL
Intervention: CCK10 plus GTN
Number of subjects: 31

Group type: COMPARATOR
Intervention: CCK10 alone
Number of subjects: 31

Group type: COMPARATOR
Intervention: Placebo plus CCK10
Number of subjects: 31
Study: 12475452

Group type: EXPERIMENTAL
Intervention: Oral prednisone for 45 days
Number of subjects: 83

Group type: COMPARATOR
Intervention: Placebo for 45 days
Number of subjects: 83
Study: 9972754

Group type: EXPERIMENTAL
Intervention: Intrathecal morphine (25-200 microg)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Patient-controlled analgesia with i.v. morphine (historical group)
Number of subjects: 40
Study: 7476333

Group type: EXPERIMENTAL
Intervention: Fluvastatin (FLUV) 40 mg/d
Number of subjects: 100

Group type: COMPARATOR
Intervention: Cholestyramine (CME) 16 g/d
Number of subjects: 100
Study: 1827213

Group type: EXPERIMENTAL
Intervention: Ipratropium bromide delivered by metered-dose aerosol plus spacer and mask (MDA group)
Number of subjects: 32

Group type: COMPARATOR
Intervention: Ipratropium bromide delivered by conventional nebulisation
Number of subjects: 32
Study: 7053953

Group type: COMPARATOR
Intervention: Manufacturer's instruction sheet
Number of subjects: 42

Group type: EXPERIMENTAL
Intervention: Counseling from a pharmacist
Number of subjects: 42

Group type: EXPERIMENTAL
Intervention: Both manufacturer's instruction sheet and counseling from a pharmacist
Number of subjects: 42
Study: 30395051

Group type: EXPERIMENTAL
Intervention: Impact loading + resistance training (ImpRes)
Number of subjects: 154

Group type: COMPARATOR
Intervention: Delayed aerobic exercise (DelAer)
Number of subjects: 154
Study: 28338164

Group type: EXPERIMENTAL
Intervention: Laparoscopic repair (LR)
Number of subjects: 119

Group type: COMPARATOR
Intervention: Open repair (OR)
Number of subjects: 119
Study: 27969034

Group type: EXPERIMENTAL
Intervention: Support Program
Number of subjects: 70

Group type: COMPARATOR
Intervention: Control Group
Number of subjects: 70
Study: 23183194

Group type: EXPERIMENTAL
Intervention: CRT-D
Number of subjects: 1820
Study: 21468625

Group type: EXPERIMENTAL
Intervention: Laparoscopic gastric bypass (LGBP)
Number of subjects: 68

Group type: EXPERIMENTAL
Intervention: Laparoscopic sleeve gastrectomy (LSG)
Number of subjects: 68
Study: 18479627

Group type: EXPERIMENTAL
Intervention: No drain
Number of subjects: 55

Group type: COMPARATOR
Intervention: Drain
Number of subjects: 55
Study: 16432111

Group type: EXPERIMENTAL
Intervention: PRECiSe low prime volume system
Number of subjects: 80

Group type: COMPARATOR
Intervention: Standard heart-lung machine
Number of subjects: 80
Study: 12676276

Group type: EXPERIMENTAL
Intervention: Calcium taste preference in hemodialysis patients
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Calcium taste preference in cheese
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Calcium appetite related to perturbed calcium metabolism
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Calcium added to foods for hemodialysis patients
Number of subjects: 20
Study: 10743489

Group type: EXPERIMENTAL
Intervention: High flavour level yoghurt
Number of subjects: 380

Group type: COMPARATOR
Intervention: Low flavour level yoghurt
Number of subjects: 380

Group type: EXPERIMENTAL
Intervention: Flavour-amplified yoghurt
Number of subjects: 380

Group type: EXPERIMENTAL
Intervention: Age, sex, BMI, and odour perception
Number of subjects: 380

Group type: EXPERIMENTAL
Intervention: BMI
Number of subjects: 380

Group type: EXPERIMENTAL
Intervention: Odour perception
Number of subjects: 380
Study: 9374950

Group type: EXPERIMENTAL
Intervention: Same admission cardiac catheterization
Number of subjects: 100

Group type: COMPARATOR
Intervention: Year of admission
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Recurrence of chest pain and evidence of myocardial necrosis
Number of subjects: 100
Study: 1357242

Group type: EXPERIMENTAL
Intervention: Lithotripsy
Number of subjects: 163

Group type: EXPERIMENTAL
Intervention: Cholecystectomy
Number of subjects: 163
Study: 3920891

Group type: EXPERIMENTAL
Intervention: verapamil
Number of subjects: 17

Group type: COMPARATOR
Intervention: placebo
Number of subjects: 17
Study: 30073685

Group type: EXPERIMENTAL
Intervention: Blinded sample size reestimation procedures
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Unblinded sample size reestimation procedures
Number of subjects: 0

Group type: COMPARATOR
Intervention: Conventional SW-CRT design
Number of subjects: 0
Study: 28994889

Group type: EXPERIMENTAL
Intervention: Beat-to-beat heart rate slope during six-minute walk test (6MWTS)
Number of subjects: 70

Group type: EXPERIMENTAL
Intervention: Recovery slope
Number of subjects: 70
Study: 25556427

Group type: EXPERIMENTAL
Intervention: Metformin (500mg Bid)
Number of subjects: 43

Group type: COMPARATOR
Intervention: Megestrol (40mg daily)
Number of subjects: 43
Study: 22223747

Group type: EXPERIMENTAL
Intervention: Sonomed UBM (SUBM)
Number of subjects: 27

Group type: COMPARATOR
Intervention: Humphrey UBM (HUBM)
Number of subjects: 27
Study: 20131372

Group type: EXPERIMENTAL
Intervention: Coenzyme Q(10)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: GPI-1485
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 18597597

Group type: EXPERIMENTAL
Intervention: SRP and laser (SRPL)
Number of subjects: 21

Group type: EXPERIMENTAL
Intervention: Laser only (L)
Number of subjects: 21

Group type: EXPERIMENTAL
Intervention: SRP only (SRP)
Number of subjects: 21

Group type: COMPARATOR
Intervention: No treatment (C)
Number of subjects: 21
Study: 17697395

Group type: EXPERIMENTAL
Intervention: Escitalopram
Number of subjects: 18

Group type: COMPARATOR
Intervention: Control (healthy age-matched subjects)
Number of subjects: 18
Study: 14990521

Group type: EXPERIMENTAL
Intervention: Cognitive-behavioural therapy (CBT)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Supportive counselling
Number of subjects: 0

Group type: COMPARATOR
Intervention: Treatment as usual (TAU)
Number of subjects: 0
Study: 11403713

Group type: EXPERIMENTAL
Intervention: 50 Hz magnetic field exposure (28 microT, circularly polarized) for 50 minutes
Number of subjects: 30

Group type: COMPARATOR
Intervention: Sham exposure (control) for 50 minutes
Number of subjects: 30
Study: 9240942

Group type: EXPERIMENTAL
Intervention: Heparin thromboprophylaxis
Number of subjects: 3809